Concepedia

Elizabeth Crowley

EC

Statistics

Publications

26

Citations

1.3K

H-Index

18

Active since

2006

Affiliations

Massachusetts General Hospital(Current)

Celldex Therapeutics (United States)

Cornell University

Sepragen Corporation (United States)

Charité - Universitätsmedizin Berlin

Elizabeth Crowley is an author at Massachusetts General Hospital specializing in oncology, medicine, and pharmacology.

Publications per year

2006–2025

26

Publications

26

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer

Denise A. Yardley, Robert Weaver, Michelle Melisko et al. · Journal of Clinical Oncology · 2015 · 189 citations · Full text

Medicine, Oncology, Pharmacology +17

Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria

Dorothea Terhorst‐Molawi, Tomasz Hawro, Eva Grekowitz et al. · Allergy · 2022 · 121 citations · Full text

Life Sciences, Dermatology, Immunology +17

Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer

Johanna C. Bendell, Mansoor N. Saleh, April A. N. Rose et al. · Journal of Clinical Oncology · 2014 · 108 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma

Patrick A. Ott, Omid Hamid, Anna C. Pavlick et al. · Journal of Clinical Oncology · 2014 · 98 citations

Pharmacy, Oncology, Pharmacology +17

A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours

Ulrik Lassen, L. Rhoda Molife, Engelholm Sa et al. · British Journal of Cancer · 2010 · 88 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 26